scispace - formally typeset
X

Xavier León

Researcher at Autonomous University of Barcelona

Publications -  229
Citations -  5776

Xavier León is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Medicine. The author has an hindex of 36, co-authored 201 publications receiving 4802 citations. Previous affiliations of Xavier León include Complutense University of Madrid & Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

Xavier Castellsagué, +61 more
TL;DR: This large international study to estimate fractions of head and neck cancers attributable to human papillomavirus (HPV-AFs) using six HPV-related biomarkers of viral detection, transcription, and cellular transformation confirms the important role ofHPVs in oropharyngeal cancer and drastically downplays the previously reported involvement of HPVs in the other HNCs.
Journal ArticleDOI

Second neoplasm in patients with head and neck cancer.

TL;DR: The improvement in locoregional control of head and neck carcinomas over the last decades does not appear to modify the final survival of these patients, mainly due to the appearance of distant metastases and second neoplasms.
Journal ArticleDOI

High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

TL;DR: Vectors purified by the optimized CsCl protocol were found to be comparable in purity and functional activity to those prepared by more scalable, but less flexible serotype-specific purification processes developed for manufacture of clinical vectors, and are ideally suited for pre-clinical studies supporting translational research.
Journal ArticleDOI

Distant metastases in head and neck cancer patients who achieved loco-regional control

TL;DR: The objective of this study was to evaluate the frequency of distant metastases in patients with head and neck carcinoma and to determine the relative role of several prognostic factors in the subsequent development of distant cancer metastases.
Journal ArticleDOI

FGF21 gene therapy as treatment for obesity and insulin resistance

TL;DR: FGF21 overproduction in healthy animals fed a standard diet prevented the increase in weight and insulin resistance associated with aging and underscores the potential of FGF21 gene therapy to treat obesity, insulin resistance, and T2D.